Top

Gepubliceerd in:

19-05-2022

Utility values and its time to deterioration in breast cancer patients after diagnosis and during treatments

Auteurs: Rana El Haidari, Amelie Anota, Tienhan S. Dabakuyo-Yonli, Francis Guillemin, Thierry Conroy, Michel Velten, Damien Jolly, Sylvain Causeret, Jean Cuisenier, Olivier Graesslin, Linda Abou Abbas, Virginie Nerich

Gepubliceerd in: Quality of Life Research | Uitgave 10/2022

Abstract

Background

The potential effects of breast cancer (BC) on health-related quality of life (HRQoL) should be considered in clinical and policy decision-making, as the economic burden of BC management is currently assessed. In the last decades, time-to-HRQoL score deterioration (TTD) has been proposed as an approach to the analysis of longitudinal HRQoL in oncology. The main objectives of the current study were to investigate the evolution of the utility values in BC patients after diagnosis and during follow-ups and to evaluate the TTD in utility values among women in all stages of BC.

Methods

Health-state utility values (HSUV) were assessed using the EuroQol 5-Dimension 3-Level at diagnosis, at the end of the first hospitalization and 3 and 6 months after the first hospitalization. For a given baseline score, HSUV was considered to have deteriorated if this score decreased by ≥ 0.08 points of the EQ-5D utility index score and ≥ 7 points of the EQ visual analogue scale. TTD curves were calculated using the Kaplan–Meier estimation method.

Results

Overall 381 patients were enrolled between February 2006 and February 2008. The highest proportions of respondents at the baseline and all follow-ups reporting some and extreme problems were in pain discomfort and anxiety/depression dimensions; more than 80% of patients experienced a deterioration in EQ-5D utility index score and EQ VAS score with a median TTD of 3.15 months and 6.24 Months, respectively.

Conclusions

BC patients undergoing therapy need psychological support to cope with their discomfort, pain, depression, anxiety, and fear during the process of diagnosis and treatment to improve their QoL.

vorige artikel The prototype of a preference-based index of weight-related quality of life: demonstrating the possibilities

volgende artikel Correction to: Time trade‑off with someone to live for: impact of having significant others on time trade‑off valuations of hypothetical health states

Alleen toegankelijk voor geautoriseerde gebruikers

Foster, T. S., Miller, J. D., Boye, M. E., Blieden, M. B., Gidwani, R., & Russell, M. W. (2011). The economic burden of metastatic breast cancer: a systematic review of literature from developed countries. Cancer Treatment Reviews, 37, 405–415. https://doi.org/10.1016/j.ctrv.2010.12.008CrossRefPubMed

Ji, P., Gong, Y., Jin, M.-L., Hu, X., Di, G.-H., Shao, Z.-M., & Burden and Trends of Breast Cancer From,. (1990). to 2017 at the global, regional, and national levels: results from the global burden of disease study 2017. Frontiers in Oncology, 2020, 10. https://doi.org/10.3389/fonc.2020.00650CrossRef

Bodai, B. I., & Tuso, P. (2015). Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J, 19, 48–79. https://doi.org/10.7812/TPP/14-241CrossRefPubMedPubMedCentral

Lovelace, D. L., McDaniel, L. R., & Golden, D. (2019). Long-term effects of breast cancer surgery, treatment, and survivor care. Journal of Midwifery & Women’s Health, 64, 713–724. https://doi.org/10.1111/jmwh.13012CrossRef

Paraskevi, T. (2012). Quality of life outcomes in patients with breast cancer. Oncology Reviews, 6, e2. https://doi.org/10.4081/oncol.2012.e2CrossRefPubMedPubMedCentral

Canário, A. C. G., Cabral, P. U. L., Paiva, L. C., de; Florencio, G.L.D., Spyrides, M.H., Gonçalves, A.K. da S., Canário, A.C.G., Cabral, P.U.L., Paiva, L.C. de; Florencio, G.L.D., et al. (2016). Physical activity, fatigue and quality of life in breast cancer patients. Revista da Associação Médica Brasileira, 62, 38–44. https://doi.org/10.1590/1806-9282.62.01.38CrossRefPubMed

Villar, R. R., Fernández, S. P., Garea, C. C., Pillado, M. T. S., Barreiro, V. B., & Martín, C. G. (2017). Quality of life and anxiety in women with breast cancer before and after treatment. Revista Latino-Americana de Enfermagem. https://doi.org/10.1590/1518-8345.2258.2958CrossRefPubMedPubMedCentral

Sheppard, C. (2007). Breast cancer follow-up: literature review and discussion. European Journal of Oncology Nursing, 11, 340–347. https://doi.org/10.1016/j.ejon.2006.09.001CrossRefPubMed

Gérard, C., Fagnoni, P., Vienot, A., Borg, C., Limat, S., Daval, F., Calais, F., Vardanega, J., Jary, M., & Nerich, V. (2017). A systematic review of economic evaluation in pancreatic ductal adenocarcinoma. European Journal of Cancer, 86, 207–216. https://doi.org/10.1016/j.ejca.2017.08.035CrossRefPubMed

10.

Couchoud, C., Fagnoni, P., Aubin, F., Westeel, V., Maurina, T., Thiery-Vuillemin, A., Gerard, C., Kroemer, M., Borg, C., Limat, S., et al. (2020). Economic evaluations of cancer immunotherapy: a systematic review and quality evaluation. Cancer Immunology, Immunotherapy, 69, 1947–1958. https://doi.org/10.1007/s00262-020-02646-0CrossRefPubMed

11.

Nerich, V., Saing, S., Gamper, E. M., Kemmler, G., Daval, F., Pivot, X., & Holzner, B. (2016). Cost-utility analyses of drug therapies in breast cancer: a systematic review. Breast Cancer Research and Treatment, 159, 407–424. https://doi.org/10.1007/s10549-016-3924-7CrossRefPubMed

12.

Cost Utility Analysis - an Overview | ScienceDirect Topics Available online: https://www.sciencedirect.com/topics/nursing-and-health-professions/cost-utility-analysis (accessed on 10 March 2021).

13.

Cochrane Handbook for Systematic Reviews of Interventions Available online: https://handbook-5-1.cochrane.org/ (accessed on 10 March 2021).

14.

Whitehead, S. J., & Ali, S. (2010). Health outcomes in economic evaluation: the QALY and utilities. British Medical Bulletin, 96, 5–21. https://doi.org/10.1093/bmb/ldq033CrossRefPubMed

15.

Peasgood, T., Ward, S. E., & Brazier, J. (2010). Health-state utility values in breast cancer. Expert Review of Pharmacoeconomics & Outcomes Research, 10, 553–566. https://doi.org/10.1586/erp.10.65CrossRef

16.

Shih, V., Chan, A., Xie, F., & Ko, Y. (2012). Health state utility assessment for breast cancer. Value in Health Regional Issues, 1, 93–97. https://doi.org/10.1016/j.vhri.2012.03.009CrossRefPubMed

17.

Kim, S.-H., Jo, M.-W., Ock, M., Lee, H.-J., & Lee, J.-W. (2017). Estimation of health state utilities in breast cancer. Patient Preference and Adherence, 11, 531–536. https://doi.org/10.2147/PPA.S129856CrossRefPubMedPubMedCentral

18.

Yang, Q., Yu, X., & Zhang, W. (2020). Health variations among breast-cancer patients from different disease states: evidence from China. BMC Health Services Research, 20, 1033. https://doi.org/10.1186/s12913-020-05872-5CrossRefPubMedPubMedCentral

19.

Gong, X.-H., Wang, J.-W., Li, J., Chen, X.-F., Sun, L., Yuan, Z.-P., & Yu, J.-M. (2017). Physical exercise, vegetable and fruit intake and health-related quality of life in chinese breast cancer survivors: a cross-sectional study. Quality of Life Research, 26, 1541–1550. https://doi.org/10.1007/s11136-017-1496-6CrossRefPubMed

20.

Paracha, N., Thuresson, P.-O., Moreno, S. G., & MacGilchrist, K. S. (2016). Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research, 16, 549–559. https://doi.org/10.1080/14737167.2016.1222907CrossRef

21.

Bascoul-Mollevi, C., Barbieri, A., Bourgier, C., Conroy, T., Chauffert, B., Hebbar, M., Jacot, W., Juzyna, B., De Forges, H., Gourgou, S., et al. (2021). Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results. Quality of Life Research, 30, 91–103. https://doi.org/10.1007/s11136-020-02605-3CrossRefPubMed

22.

Anota, A., Hamidou, Z., Paget-Bailly, S., Chibaudel, B., Bascoul-Mollevi, C., Auquier, P., Westeel, V., Fiteni, F., Borg, C., & Bonnetain, F. (2015). Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need recist for quality of life to achieve standardization? Quality of Life Research, 24, 5–18. https://doi.org/10.1007/s11136-013-0583-6CrossRefPubMed

23.

Bonnetain, F., Dahan, L., Maillard, E., Ychou, M., Mitry, E., Hammel, P., Legoux, J.-L., Rougier, P., Bedenne, L., & Seitz, J.-F. (2010). Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma. European Journal of Cancer, 46, 2753–2762. https://doi.org/10.1016/j.ejca.2010.07.023CrossRefPubMed

24.

Dabakuyo, T. S., Guillemin, F., Conroy, T., Velten, M., Jolly, D., Mercier, M., Causeret, S., Cuisenier, J., Graesslin, O., Gauthier, M., et al. (2013). Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study. Quality of Life Research, 22, 1–11. https://doi.org/10.1007/s11136-012-0135-5CrossRefPubMed

25.

Hamidou, Z., Dabakuyo-Yonli, T. S., Guillemin, F., Conroy, T., Velten, M., Jolly, D., Causeret, S., Graesslin, O., Gauthier, M., Mercier, M., et al. (2014). Impact of response shift on time to deterioration in quality of life scores in breast cancer patients. PLoS ONE. https://doi.org/10.1371/journal.pone.0096848CrossRefPubMedPubMedCentral

26.

EQ-5D Instruments – EQ-5D.

27.

Chevalier, J., & de Pouvourville, G. (2013). Valuing EQ-5D using time trade-off in France. The European Journal of Health Economics, 14, 57–66. https://doi.org/10.1007/s10198-011-0351-xCrossRefPubMed

28.

Pickard, A. S., Neary, M. P., & Cella, D. (2007). Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health and Quality of Life Outcomes, 5, 70. https://doi.org/10.1186/1477-7525-5-70CrossRefPubMedPubMedCentral

29.

Valderas, J. M., Starfield, B., Sibbald, B., Salisbury, C., & Roland, M. (2009). Defining comorbidity: implications for understanding health and health services. Annals of Family Medicine, 7, 357–363. https://doi.org/10.1370/afm.983CrossRefPubMedPubMedCentral

30.

Liu, L., Li, S., Wang, M., & Chen, G. (2017). Comparison of EQ-5D-5L health state utilities using four country-specific tariffs on a breast cancer patient sample in Mainland China. Patient Preference and Adherence, 11, 1049–1056. https://doi.org/10.2147/PPA.S138028CrossRefPubMedPubMedCentral

31.

Chávarri-Guerra, Y., Villarreal-Garza, C., Liedke, P. E. R., Knaul, F., Mohar, A., Finkelstein, D. M., & Goss, P. E. (2012). Breast cancer in Mexico: a growing challenge to health and the health system. The lancet Oncology, 13, e335-343. https://doi.org/10.1016/S1470-2045(12)70246-2CrossRefPubMed

32.

Setyowibowo, H., Purba, F. D., Hunfeld, J. A. M., Iskandarsyah, A., Sadarjoen, S. S., Passchier, J., & Sijbrandij, M. (2018). Quality of life and health status of indonesian women with breast cancer symptoms before the definitive diagnosis: a comparison with indonesian women in general. PLoS ONE, 13, e0200966. https://doi.org/10.1371/journal.pone.0200966CrossRefPubMedPubMedCentral

33.

Lumley, M. A., Cohen, J. L., Borszcz, G. S., Cano, A., Radcliffe, A. M., Porter, L. S., Schubiner, H., & Keefe, F. J. (2011). Pain and emotion: a biopsychosocial review of recent research. Journal of Clinical Psychology, 67, 942–968. https://doi.org/10.1002/jclp.20816CrossRefPubMedPubMedCentral

34.

Rottmann, N., Dalton, S. O., Christensen, J., Frederiksen, K., & Johansen, C. (2010). Self-Efficacy, adjustment style and well-being in breast cancer patients: a longitudinal study. Quality of Life Research, 19, 827–836. https://doi.org/10.1007/s11136-010-9653-1CrossRefPubMed

35.

Cho, Y. U., Lee, B. G., & Kim, S. H. (2020). Coping style at diagnosis and its association with subsequent health-related quality of life in women with breast cancer: a 3-year follow-up study. European Journal of Oncology Nursing, 45, 101726. https://doi.org/10.1016/j.ejon.2020.101726CrossRefPubMed

36.

Roine, E., Sintonen, H., Kellokumpu-Lehtinen, P.-L., Penttinen, H., Utriainen, M., Vehmanen, L., Huovinen, R., Kautiainen, H., Nikander, R., Blomqvist, C., et al. (2020). Health-related quality of life of breast cancer survivors attending an exercise intervention study: a five-year follow-up. In Vivo, 34, 667–674. https://doi.org/10.21873/invivo.11821CrossRefPubMedPubMedCentral

37.

Binotto, M., Reinert, T., Werutsky, G., Zaffaroni, F., & Schwartsmann, G. (2020). Health-Related Quality of Life before and during Chemotherapy in Patients with Early-Stage Breast Cancer. Ecancermedicalscience, 14, 1007. https://doi.org/10.3332/ecancer.2020.1007CrossRefPubMedPubMedCentral

38.

Timperi, A. W., Ergas, I. J., Rehkopf, D. H., Roh, J. M., Kwan, M. L., & Kushi, L. H. (2013). Employment status and quality of life in recently diagnosed breast cancer survivors. Psycho-Oncology, 22, 1411–1420. https://doi.org/10.1002/pon.3157CrossRefPubMed

39.

Avis, N. E., Crawford, S., & Manuel, J. (2005). Quality of life among younger women with breast cancer. JCO, 23, 3322–3330. https://doi.org/10.1200/JCO.2005.05.130CrossRef

40.

Miller, A. M., Ashing, K. T., Modeste, N. N., Herring, R. P., & Sealy, D.-A.T. (2015). Contextual factors influencing health-related quality of life in african american and latina breast cancer survivors. Journal of Cancer Survivorship, 9, 441–449. https://doi.org/10.1007/s11764-014-0420-0CrossRefPubMedPubMedCentral

41.

Ho, P. J., Gernaat, S. A. M., Hartman, M., & Verkooijen, H. M. (2018). Health-related quality of life in asian patients with breast cancer: a systematic review. British Medical Journal Open, 8, e020512. https://doi.org/10.1136/bmjopen-2017-020512CrossRef

42.

Bloom, J. R., Stewart, S. L., Napoles, A. M., Hwang, E. S., Livaudais, J. C., Karliner, L., & Kaplan, C. P. (2013). Quality of life of latina and euro-american women with ductal carcinoma in situ. Psycho-Oncology, 22, 1008–1016. https://doi.org/10.1002/pon.3098CrossRefPubMed

43.

Jarvandi, S., Pérez, M., Schootman, M., & Jeffe, D. B. (2016). Pre-existing diabetes in early stage breast cancer patients is associated with lack of improvement in quality of life 2 years after diagnosis. International Journal of Behavioral Medicine, 23, 722–729. https://doi.org/10.1007/s12529-016-9577-4CrossRefPubMedPubMedCentral

44.

Schoormans, D., Czene, K., Hall, P., & Brandberg, Y. (2015). The impact of Co-morbidity on health-related quality of life in breast cancer survivors and controls. Acta Oncologica, 54, 727–734. https://doi.org/10.3109/0284186X.2014.998277CrossRefPubMed

Titel: Utility values and its time to deterioration in breast cancer patients after diagnosis and during treatments
Auteurs: Rana El Haidari
Amelie Anota
Tienhan S. Dabakuyo-Yonli
Francis Guillemin
Thierry Conroy
Michel Velten
Damien Jolly
Sylvain Causeret
Jean Cuisenier
Olivier Graesslin
Linda Abou Abbas
Virginie Nerich
Publicatiedatum: 19-05-2022
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 10/2022
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-022-03157-4

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Background

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 10/2022

Reducing research wastage by starting off on the right foot: optimally framing the research question

Multidimensional frailty and quality of life: data from the English Longitudinal Study of Ageing

Knowledge translation concerns for the CONSORT-PRO extension reporting guidance: a review of reviews

Correction to: Time trade‑off with someone to live for: impact of having significant others on time trade‑off valuations of hypothetical health states

Criteria for developing, assessing and selecting candidate EQ-5D bolt-ons

Reducing waste in collection of quality-of-life data through better reporting: a case study